CorMedix CRMD
$5.27 +$0.19 (+3.74%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $5.32 +0.95%
Open$4.96
Prev close$5.08
Day range$4.95 – $5.32
Volume3.61M
Market cap$419.16M
P/E (TTM)8.2
Dividend yield–
CRMD Stock News
Headlines matching CorMedix or the CRMD ticker, most recent first.
- Analysts Are Bullish on Top Healthcare Stocks: Parabilis Medicines, Inc. (PBLS), Cormedix (CRMD) Positive
- Needham Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $15
- H.C. Wainwright Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $13
- RBC Capital Maintains CorMedix(CRMD.US) With Buy Rating, Raises Target Price to $14 Positive
- RBC Capital Maintains CorMedix(CRMD.US) With Buy Rating, Cuts Target Price to $13 Negative
- Truist Financial Maintains CorMedix(CRMD.US) With Buy Rating
- A Quick Look at Today's Ratings for CorMedix(CRMD.US), With a Forecast Between $13 to $15
- RBC Capital Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $13
- Needham Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $14
- Leerink Partners Maintains CorMedix(CRMD.US) With Buy Rating, Announces Target Price $13
- Needham Maintains CorMedix(CRMD.US) With Buy Rating, Cuts Target Price to $14 Negative
- Analysts' Top Healthcare Picks: Cormedix (CRMD), CG Oncology, Inc. (CGON)
- Oppenheimer Maintains CorMedix(CRMD.US) With Buy Rating, Announces Target Price $13
- RBC Capital Maintains CorMedix(CRMD.US) With Buy Rating, Cuts Target Price to $14 Negative
- H.C. Wainwright Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $13
No comments yet — be the first to weigh in on CRMD.
Sign in to join the discussion.